gadoteridol
Showing 1 - 8 of 8
Glioma, Malignant, High Grade Glioma, Glioblastoma Trial in Tampa (OS2966, Gadoteridol)
Active, not recruiting
- Glioma, Malignant
- +4 more
- OS2966
- Gadoteridol
-
Tampa, FloridaMoffitt Cancer Center
Nov 28, 2022
Secondary Progressive Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Salt Lake City
Recruiting
- Secondary Progressive Multiple Sclerosis
- +2 more
- Ferumoxytol infusion
- +2 more
-
Salt Lake City, UtahUniversity of Utah Health Imaging and Neurosciences Center
Jun 22, 2022
Meningeal Inflammation on 7T MRI asTool for Measuring and
Active, not recruiting
- Multiple Sclerosis
- Gadoteridol
-
Baltimore, MarylandUniversity of Maryland School of Medicine
Jan 21, 2022
Glioblastoma Trial in Columbus, Portland (Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging, Ferumoxytol,
Completed
- Glioblastoma
- Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging
- +3 more
-
Columbus, Ohio
- +1 more
Mar 11, 2022
Motor Function, Cognitive Function, Contrast Media Trial in Worldwide (Motor Tests, Cognitive Tests, Unenhanced-MRI of the
Recruiting
- Motor Function
- +2 more
- Motor Tests
- +9 more
-
Scottsdale, Arizona
- +31 more
Feb 21, 2022
Contrast Enhancement in Magnetic Resonance Imaging, CNS Pathology Trial in Worldwide (Gadoquatrane (BAY1747846), Gadobutrol,
Not yet recruiting
- Contrast Enhancement in Magnetic Resonance Imaging
- Central Nervous System Pathology
- Gadoquatrane (BAY1747846)
- +3 more
-
Indian Wells, California
- +90 more
Jun 25, 2023
Contrast Enhancement in Magnetic Resonance Imaging, Non-central Nervous System Pathology Trial in Worldwide (Gadoquatrane
Not yet recruiting
- Contrast Enhancement in Magnetic Resonance Imaging
- Non-central Nervous System Pathology
- Gadoquatrane (BAY1747846)
- +3 more
-
Birmingham, Alabama
- +106 more
Jun 25, 2023
Brain Disease Trial in Teaneck (gadoteridol, gadobutrol)
Completed
- Brain Disease
- gadoteridol
- gadobutrol
-
Teaneck, New JerseyHoly Name Medical Center
Jun 4, 2015